Thanksgiving Adjustments: GLP-1 Users Alter Medication for Holiday Enjoyment

Survey Insights: A Unique Thanksgiving for GLP-1 Users

A recent survey conducted by Sunlight.com revealed intriguing insights about GLP-1 medication users as they prepare for Thanksgiving. This comprehensive study included responses from 1,250 active GLP-1 users across the United States. According to the findings, 40% of these users are considering adjustments to their medication routines, aimed at enhancing their holiday dining experience.

For many, Thanksgiving represents not just a meal, but an opportunity to connect with family and friends. Among the surveyed users, 6% indicated that they plan to completely skip their medication dose, while 34% are contemplating changes in the timing or dosage of their current routine. The desire to enjoy Thanksgiving festivities comes with some concerns regarding the effects of skipping or altering doses. Notably, over half (51%) of those intending to skip a dose received advice from their healthcare provider against doing so. However, among those choosing to change the timing, 59% had received their doctor's approval.

Dr. Angela Tran, a respected expert in internal and obesity medicine, offered insights into the potential risks associated with such adjustments. She emphasized that without proper medical supervision, changing doses can lead to serious side effects. "These medications are highly effective for weight loss and blood sugar control, but without close oversight and clear communication from a trained medical team, adverse reactions can escalate quickly. It's essential to collaborate with a specialized medical weight loss team to ensure safety," Dr. Tran explained.

As users contemplate the effects of their medication on their holidays, motivations vary. A remarkable 74% of respondents are eager to enhance their food enjoyment, with 36% expressing discomfort about explaining reduced appetite and 31% feeling the pressure to conform to social eating norms. This highlights a dynamic interplay between dietary and social expectations during Thanksgiving.

Self-presentation plays a crucial role in how GLP-1 users perceive their experience at the family table this year. Approximately 37% plan to wear outfits that showcase their weight loss progress, whereas 29% prefer to wear clothing that conceals their bodies to avoid drawing attention. Despite their concerns, a vast 94% of respondents anticipate supportive reactions from their family regarding their food choices. Judgments are expected to be minimal, with only 8% fearing criticism for their food intake and 4% expressing apprehensions about being judged for their medication use.

In terms of future holiday gatherings, the survey reflects a desire for a broader focus beyond just food. Around 67% wish Thanksgiving to pivot more towards themes of gratitude and connection. Additionally, about 21% want less emphasis placed on food, with many looking to incorporate physical activities, like group walks or participating in charity events such as 5Ks, into the celebrations. A striking one in three users indicated they might consider making it look like they ate more than they actually did, illustrating the tension between GLP-1-induced appetite changes and traditional food-centered festivities.

With these findings, it's clear that while Thanksgiving is a time for joy and togetherness, it is also a period of careful consideration for those on GLP-1 medications. Balancing medication routines with holiday traditions remains a delicate dance, and communication with healthcare providers proves essential in ensuring safety and enjoyment.

In conclusion, GLP-1 users are navigating an intersection of health management and holiday celebration where both factors play a significant role in their Thanksgiving experience. As these individuals take steps to enjoy meals, it reinforces the importance of supporting healthier relationships with food while celebrating with loved ones.

Methodology

This survey was conducted in November 2025 via the Pollfish platform, focused on a representative sample of U.S. adults currently using GLP-1 medications. The results have a margin of error of ±3 percentage points at a 95% confidence level.

About Sunlight.com

Sunlight.com is committed to aiding individuals on their weight loss journeys by offering personalized, compassionate care supported by scientific solutions.